Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question: Rheumatology Coding & Practice Quiz

From the College  |  Issue: October 2018  |  October 18, 2018

1. A 45-year-old female patient with a diagnosis of primary osteoarthritis returns to the office for her second scheduled injection of sodium hyaluronate (Supartz). The nurse takes the patient’s vitals: weight is 185 lbs., height is 5’2”, and temperature is 98.2°F. The patient is prepped and given the injection. How should this encounter be coded?

  1. 99211-25, 20610, J7321
  2. 20610, J7321
  3. 99211-25, 20611, J7321
  4. None of the above

2. A 27-year-old female patient with a diagnosis of systemic lupus erythematous (SLE) returns to the office for her second belimumab infusion. The patient was last seen two weeks ago. The physician takes the patient’s vitals: weight is 120 lbs., temperature is 98°F, and blood pressure is 105/80. The infusion is started at 10:16 a.m. and completed at 11:05 a.m.; the dosage is 600 mg. How should this encounter be coded?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  1. 99212-25, 96365, J0490 X 60
  2. 96365, J0490 X 60
  3. 99212-25, 96413, J0490 X 60
  4. 96413, J0490 X 60

3. A 45-year-old man with a diagnosis of rheumatoid arthritis of multiple sites, rheumatoid factor positive, without organ or systems involvement, returns to the practice for his infliximab infusion. The practice does not verify that the patient’s medical coverage is still the same, because it has a prior authorization from the patient’s payer for 10 months. Is something incorrect with this scenario?

  1. Yes
  2. No

4. A practice receives notice of a Zone Program Integrity Contractor (ZPIC) audit. How should the practice handle this?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  1. Put it to the side because the practice is dealing with other audits
  2. Treat it like a regular audit, and send in requested documents
  3. Give the notice immediately to the physician or practice manager
  4. None of above

5. A practice hires someone or does business with a company that is on the Office of Inspector General’s (OIG) excluded list. What can happen to the practice as a result?

  1. The practice can be fined and given a penalty
  2. The practice can end up on the excluded list
  3. The practice must fire the person or stop doing business with the company immediately
  4. All of the above

Click here for the answer(s).

Share: 

Filed under:Billing/CodingFrom the College Tagged with:Billing & Coding

Related Articles

    Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis

    August 16, 2019

    Over the past few years, bio­similars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and small molecule inhibitor drugs…

    Oksana Shufrych TKTK / Shutterstock.com

    Heated Gloves May Improve Hand Function in Diffuse Systemic Sclerosis

    October 16, 2017

    Systemic sclerosis (SSc), a subtype of scleroderma, is a rare, complex autoimmune disease characterized by widespread vasculopathy of the small arteries and fibroblast dysfunction.1,2 It has been described as a fibrosing micro­vascular disease, because vascular injury precedes and leads to tissue fibrosis.3 The resulting Raynaud’s phenomenon, pain, skin thickening and tightening, and multi-organ involvement have…

    Coding Corner Question: A Quiz on Modifiers

    February 18, 2019

    Which modifier is used when there is a separate and/or identifiable reason to bill for both an evaluation and management code and a procedure code? -25 -24 -51 -59 Which modifier is used to indicate that bilateral procedures were done on a patient? -50 -LT/RT Both a and b None of the above A 68–year-old…

    MicroOne / shutterstock.com

    Rheumatology Drugs at a Glance, Part 2: Psoriasis

    May 17, 2019

    Over the past few years, bio­similars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug option; others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and other medications used to…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences